WDR3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.486800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.190400E-01
Normal-vs-Stage2
9.063600E-01
Normal-vs-Stage3
1.270210E-01
Normal-vs-Stage4
1.258580E-01
Stage1-vs-Stage2
2.087800E-01
Stage1-vs-Stage3
1.083960E-01
Stage1-vs-Stage4
1.321820E-02
Stage2-vs-Stage3
6.219900E-03
Stage2-vs-Stage4
1.002180E-01
Stage3-vs-Stage4
4.075300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.395200E-01
Normal-vs-AfricanAmerican
7.550200E-01
Normal-vs-Asian
5.011600E-01
Caucasian-vs-AfricanAmerican
8.988800E-01
Caucasian-vs-Asian
1.503620E-01
AfricanAmerican-vs-Asian
2.303000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.766000E-01
Normal-vs-Female
8.630000E-01
Male-vs-Female
2.605400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.962600E-01
Normal-vs-Age(41-60Yrs)
7.874200E-01
Normal-vs-Age(61-80Yrs)
9.645200E-01
Normal-vs-Age(81-100Yrs)
6.923800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.930000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.153600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.362600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.924400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.932800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.431200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.412000E-01
Normal-vs-Daily Drinker
6.622800E-01
Normal-vs-Weekly Drinker
4.260400E-01
Normal-vs-Occasional Drinker
8.167600E-01
Normal-vs-Social Drinker
9.130800E-01
Non Drinker-vs-Daily Drinker
9.413200E-01
Non Drinker-vs-Weekly Drinker
3.557600E-01
Non Drinker-vs-Occasional Drinker
9.075700E-02
Non Drinker-vs-Social Drinker
4.181400E-01
Daily Drinker-vs-Weekly Drinker
3.531200E-01
Daily Drinker-vs-Occasional Drinker
1.954810E-01
Daily Drinker-vs-Social Drinker
5.149400E-01
Weekly Drinker-vs-Occasional Drinker
4.470600E-01
Weekly Drinker-vs-Social Drinker
4.051600E-01
Occasional Drinker-vs-Social Drinker
5.571000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.135200E-01
Normal-vs-Grade 2
7.835600E-01
Normal-vs-Grade 3
9.061800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.860000E-02
Grade 1-vs-Grade 3
9.135300E-03
Grade 1-vs-Grade 4
9.135200E-01
Grade 2-vs-Grade 3
2.970400E-01
Grade 2-vs-Grade 4
7.835600E-01
Grade 3-vs-Grade 4
9.061800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.954800E-01
Normal-vs-NonDiabetic
9.354200E-01
Diabetic-vs-NonDiabetic
2.751200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.211400E-01
Normal-vs-NoPancreatitis
9.392400E-01
Pancreatitis-vs-NoPancreatitis
4.848000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.910000E-01
Normal-vs-N1
8.794400E-01
N0-vs-N1
1.068550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.246800E-01
Normal-vs-TP53-NonMutant
7.186600E-01
TP53-Mutant-vs-TP53-NonMutant
4.955600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
